Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POWR: Once Weekly PTH for Osteoporosis
NCT00065637Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Dec 2003
- Primary completion
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of teriparatide in osteoporosis, osteopenia, sponsored by University of California, San Francisco. Started Dec 2003; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on NCT00065637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065637.